DL-2-(2-Chlorophenyl) glycine CAS 141196-64-7 Intende ≥98.5% Alta Munditia Clopidogrel Intermedia
Copia cum summa puritate et stabulo Quality
Nomen chemicum: DL-2-(2-Chlorophenyl) glycine
Synonyma: H-DL-Phg(2-Cl)-OH
CAS: 141196-64-7
High Quality, Commercial Production
Nomen chemicum | DL-2-(2-Chlorophenyl) glycine |
Synonyma | H-DL-Phg(2-Cl)-OH |
CAS Number | 141196-64-7 |
CATTUS Number | RF-CC254 |
Stock Status | In Stock |
Formulae hypotheticae | C8H8ClNO2 |
M. Pondus | 185.61 |
Index refractivus | 1.603 |
Density | 1.392g/cm3 |
Shipping Condition | Uit sub Ambient Temperature |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Alba ad Off-White pulveris |
Damnum in Siccatio | ≤1.0% |
Liquescens punctum | 195.0~203.0℃ |
Chlorides | ≤1000mg/kg |
Acidum Solubility Test | secundum quid |
Assay | ≥98.5% |
Test Standard | Enterprise Standard |
Consuetudinem | Triticum aestivum;Pharmaceutical Medium |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum glycinerum DL-2-(2-Chlorophenyl) (CAS: 141196-64-7) magna qualitate, late in synthesi organica, synthesi intermediorum pharmaceuticae et activae. medicamentis pharmaceutical (API) synthesis.
glycine (CAS: 141196-64-7) medium est typice in synthesi Clopidogrel (CAS: 113665-84-2), API.
Clopidogrel in US quasi potens inhibitor aggregationis laminae in praecavens administratio eventuum ischemicorum secundariorum, incluso MI, ictu et mortes vascularium, immissa est.Clopidogrel perstringi potest in 4 gradibus (inclusa resolutione optica ad enantiomer activam S) ab DL-2-(2-Chlorophenyl) glycine (CAS: 141196-64-7), clavis gradus cyclizationis ad thienopyridinem cum formaldehyde et Acidum acetic.Dissimilis aliae thienopyridines in usu sunt, clopidogrel numerum cellularum albarum in sanguine non graviter minuit, et ideo, exercitationemonitoring album cellae sanguinis comitem, curatio necessaria non est.